News

Mothers experiencing depression have considerable challenges across multiple parenting domains , according to a global systematic ...
A motion sickness drug that treats severe depression in hours? Discover how scopolamine may revolutionize mental health treatment for millions worldwide.
After prematurely ending two phase 3 depression trials last year, Relmada Therapeutics has formally given up on the asset ...
There has been a staggering rise in mental health challenges among young people in recent years. According to a new report from the Blue Cross Blue Shield Association, diagnoses of major depressive ...
Most symptoms after stopping antidepressants are mild and don’t meet criteria for severe discontinuation syndrome, suggesting ...
Although transcranial electrical stimulation is linked to reduced depressive symptoms, the effect varies by brain stim type ...
Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.
Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and central nervous system (CNS) diseases, today ...
Published March 7 in JAMA Network Open, the study paints a global picture of the hidden mental health burden that comes with ...
Singh received the maximum fine of S$7,000 for each of the two charges. The 13-day trial began on October 14, 2024, with ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.